Latest News for DKSH Holding Stock (OTC:DKSHF)

DKSH Holding Ltd offers market expansion services in Asia. The company's services include sourcing, marketing, sales, distribution, and after-sales service. DKSH operates in four business segments: Consumer goods, Healthcare, Performance Materials, and Technology. The maximum segment by revenue, Healthcare, specializes in expansion services such as product registration, marketing, distribution, and sales for pharmaceuticals, consumer health, and over-the-counter health products as well as medical devices.

DKSH HOLDING LTD ORD by DKSH Holdings Ltd.

DKSH Holding Ltd

In addition to evaluating the safety and performance of the EMPOWER LP as a standalone pacemaker, the trial evaluated the ability of the EMBLEM S-ICD System to successfully communicate a wireless request to the LP to deliver ATP therapy. Findings from the trial met all pre-specified six-month safety and effectiveness endpoints, and demonstrated:
<ul>
<li>A major complication-free rate of&nbsp;97.5%&nbsp;after implantation of the EMPOWER LP.1</li>
<li>A communication success rate of&nbsp;98.8%&nbsp;from the EMBLEM S-ICD System to the EMPOWER LP.2</li>
<li>An ATP success rate of&nbsp;61.3%,3&nbsp;and no patient requests for deactivation of ATP or bradycardia pacing due to pain or discomfort.</li>
<li>Pacing capture thresholds, which indicate stable device fixation within the heart, of &le; 2.0 V at 0.4 ms in&nbsp;97.4%&nbsp;of patients.</li>
</ul>

News

Reported Saturday, MODULAR ATP Study Of Boston Scientific's mCRM System Meets Safety And Efficacy Endpoints

&nbsp;<a href="https://www.globenewswire.com/Tracker?data=fh9fDlG43n5pjUEFvd2voDI5zTcNc83seJ-ZeTldrGYa485XqDLfBa93uFfYXWznc-Ksa9wKIfwADC9wx5IvYsrVIlWtweHruFgpAeQMCwg=" target="_blank">Dyne Therapeutics, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced it now plans to report new efficacy and safety data from its Phase 1/2 ACHIEVE and DELIVER clinical trials on May 20, 2024, and to host a virtual event at 8:00 a.m. ET. This represents an update to Dyne&#39;s prior&nbsp;guidance&nbsp;for the second half of 2024. The company intends to issue a press release prior to the start of the event.&nbsp;

Reported Sunday, Dyne Therapeutics Announces Virtual Event To Unveil New Clinical Data From ACHIEVE And DELIVER Trials

Below are summaries of the posters presented:
Poster Board 701: &quot;Healthcare Burden of Pulmonary Alveolar Proteinosis&quot; presented by E. Lee, M.D., Ph.D.; sponsored by Savara Inc.
<ul>
<li>Presented data from a retrospective cohort analysis using a longitudinal claims database (IPM.ai) comparing the clinical and economic burden of a sample of 2,312 pulmonary alveolar proteinosis (PAP) patients to 9,247 non-PAP matched controls.</li>
<li>Data demonstrated PAP patients experience higher healthcare resource utilization and higher pharmaceutical and non-pharmaceutical costs as evidenced by a 4-fold increase in hospital admissions, 6-fold increase in in-patient visits, and a 4-fold increase in cost of care, as well as higher rates of comorbidities, procedures, and therapy use (all parameters p&lt;0.001), thereby highlighting a significant unmet need in this rare disease patient population.</li>
<li>Click&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.atsjournals.org%2Fdoi%2Fabs%2F10.1164%2Fajrccm-conference.2024.209.1_MeetingAbstracts.A1173&amp;esheet=54001735&amp;newsitemid=20240519208921&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=e85d1cda08960b9d2dea68cca138c8a1">here</a>&nbsp;to view the abstract.</li>
<li>Lee E, Ataya A, McCarthy C, Cosenza J, Bielecki S, Wang TS. Healthcare burden of pulmonary alveolar proteinosis.&nbsp;Am J Respir Crit Care Med&nbsp;2024;209:A1173.</li>
</ul>
Poster Board 702: &quot;Development of a Novel Laboratory Test for the Detection of GM-CSF Antibodies to Aid in the Diagnosis of Individuals At-risk for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)&quot; presented by A. Ali and J. Kim of Trillium Health LLC
<ul>
<li>Presented data on the development and performance characteristics of a novel laboratory test for the detection of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in human serum to aid in the diagnosis of aPAP.</li>
<li>Clinical accuracy of&nbsp;100%&nbsp;was achieved in a cohort of 40 subjects (negative cohort n=20, positive cohort n=20), demonstrating Trillium&#39;s particle-based flow cytometry immunoassay test offers a highly precise and sensitive laboratory test for the determination of GM-CSF antibody levels in human serum and, thus, can successfully be used as a tool to definitively diagnose aPAP.</li>
<li>Click&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.atsjournals.org%2Fdoi%2Fabs%2F10.1164%2Fajrccm-conference.2024.209.1_MeetingAbstracts.A1174&amp;esheet=54001735&amp;newsitemid=20240519208921&amp;lan=en-US&amp;anchor=here&amp;index=3&amp;md5=0a4c1a5d36727cb41546b2bb2253b3c8">here</a>&nbsp;to view the abstract.</li>
<li>Kim J, Cornish D, Ali A. Development of a novel laboratory test for the detection of GM-CSF antibodies to aid in the diagnosis of individuals at-risk for autoimmune pulmonary alveolar proteinosis (aPAP).&nbsp;Am J Respir Crit Care Med&nbsp;2024;209:A1174.</li>
</ul>

SVRA

Reported Sunday, Savara And Trillium Health Presented New Data On Autoimmune Pulmonary Alveolar Proteinosis At ATS 2024

According to renowned analyst Ming-Chi Kuo, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) could introduce a new color option for its <a href="https://www.benzinga.com/news/24/04/38086575/iphone-16-rumors-roundup-everything-we-know-about-apples-next-flagship">upcoming smartphone lineup</a>.
What Happened: Kuo, an analyst at TF Securities, on Sunday shared his latest prediction stating the color options for the upcoming iPhone 16 lineup, set to be launched in the fall of 2024. 
According to Kuo, the iPhone 16 and iPhone 16 Plus will retain the same color options as the current iPhone 15 lineup, except the pale yellow color, which will be replaced with &#8220;white.&#8221; 
For the iPhone 16 Pro and iPhone 16 Pro Max models, Kuo expects the &#8220;Natural Titanium,&#8221; &#8220;Black Titanium,&#8221; and &#8220;White Titanium&#8221; options to remain, with the exclusion of the current &#8220;Blue Titanium&#8221; option. This will be replaced by a new &#8220;Rose Titanium&#8221; selection.
See Also: <a href="https://www.benzinga.com/news/24/05/38887887/tim-cook-touts-powerful-new-features-as-apple-introduces-ways-for-users-to-control-iphones-by-simply?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tim Cook Touts &#8216;Powerful New Features&#8217; As Apple Introduces Ways For Users To Control iPhones By Simply Moving Their Eyes</a>
Kuo also said, &#8220;Apple may rename colors (e.g., previously called white as starlight). Also, even if the color name is the same as the existing model, it may look different.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">2H24 iPhone 16系列機殼顏色預測 iPhone 16 Pro &amp; Pro Max：黑色、白色 (或銀色)、灰色 (應該是原色鈦金屬)、玫瑰 iPhone 16 &amp; 16 Plus：黑色、綠色、粉紅、藍色、白色 Apple可能對顏色會有不同的稱呼 (如先前稱呼白色為星光色)。此外，即便顏色名稱與既有機種相同，但看起來可能會不一樣。 &#8211;…
&mdash; 郭明錤 (Ming-Chi Kuo) (@mingchikuo) <a href="https://twitter.com/mingchikuo/status/1792223282361680169?ref_src=twsrc%5Etfw">May 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Kuo&#8217;s prediction aligns with another rumor from March, which suggested that the iPhone 16 Pro lineup would feature new color variants, with the <a href="https://www.benzinga.com/news/24/03/37951355/is-iphone-16-pro-going-retro-new-leak-hints-at-comeback-of-iphone-6s-vibes-from-9-years-ago">&#8216;Blue Titanium&#8217; color being replaced</a> with a new &#8216;rose&#8217; shade. The &#8216;space black&#8217; color, believed to be similar to the color of the iPhone 14 Pro, was also rumored to replace &#8216;Black Titanium.&#8217;
Meanwhile, the iPhone 16 series has been generating significant buzz ahead of its expected launch in September. It is anticipated to <a href="https://www.benzinga.com/news/23/05/32524166/apples-iphone-16-pro-max-design-leak-reveals-impossibly-gigantic-display">feature larger screens</a>, a revamped design, and improved performance, among other upgrades. 
The iPhone 16 Pro models are also rumored to feature a <a href="https://www.benzinga.com/news/24/03/38016352/apples-iphone-16-pro-to-feature-a-polished-titanium-finish-new-leak-suggests">new polished titanium finish</a>, with a different finish for each color variant, possibly more polished and scratch-resistant than the current brushed titanium look of the iPhone 15 Pro.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: <a href="https://www.benzinga.com/news/24/05/38887772/google-seeks-to-repeat-chromebook-success-in-education-by-rolling-out-gemini-ai-for-schools-promises?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Google Seeks To Repeat Chromebook Success In Education By Rolling Out &#8216;Gemini&#8217; AI For Schools, Promises Enhanced Data Privacy</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Tech

AAPL

Apple's iPhone 16 Pro Models To Ditch Blue For Rose Titanium — Analyst Ming-Chi Kuo Predicts New Color Options

Business Outlook
For the second&nbsp;quarter of 2024, Sohu estimates:
<ul>
<li>Brand advertising revenues to be between&nbsp;US$18 million&nbsp;and&nbsp;US$20 million; this implies an annual decrease of 16% to 25%,&nbsp;and a sequential increase of 12%&nbsp;to 24%.</li>
<li>Online game revenues to be between US$133&nbsp;million and US$143&nbsp;million; this implies an annual increase of 12% to 21%,&nbsp;and a sequential increase of 13%&nbsp;to&nbsp;21%.&nbsp;</li>
<li>Non-GAAP net loss attributable to Sohu.com Limited to be between US$27&nbsp;million&nbsp;and US$37&nbsp;million; and GAAP net loss attributable to Sohu.com Limited to be between US$30&nbsp;million and&nbsp;US$40&nbsp;million.</li>
</ul>
For the second&nbsp;quarter 2024 guidance, the Company has adopted a presumed exchange rate of&nbsp;RMB7.10=US$1.00, as compared with the actual exchange rate of approximately&nbsp;RMB7.00=US$1.00&nbsp;for the second&nbsp;quarter of 2023, and&nbsp;RMB7.10=US$1.00&nbsp;for the first&nbsp;quarter of 2024.

Earnings

Guidance

SOHU

Sohu.Com For Q2 Expects Brand Advertising Revenues Of $18M-$20M Down 16%-25% YoY, Online Game Revenues $133M-$143M Up 12%-21% YoY; Sees Adjusted Net Loss Of $27M-$37M

<ul>
<li>For PC games, total average monthly active user accounts[3]&nbsp;(MAU) were 2.3 million, an increase of 5% year-over-year and a decrease of 1% quarter-over-quarter. Total quarterly aggregate active paying accounts[4]&nbsp;(APA) were 0.9 million, an increase of 1% year-over-year and 3% quarter-over-quarter.</li>
<li>For mobile games, total average MAU were 2.8 million, an increase of 71% year-over-year and 63% quarter-over-quarter. The year-over-year and quarter-over-quarter increases in MAU were mainly from Haikyu!!FLY HIGH that we launched in&nbsp;Japan&nbsp;and&nbsp;South Korea&nbsp;during the quarter. Total quarterly APA were 0.3 million, flat year-over-year and a decrease of 2% quarter-over-quarter.</li>
</ul>

Sohu.com Q1 PC Games Total Average MAU Were Of 2.3M, An Increase Of 5% YoY; Mobile Games, Total Average MAU Were 2.8M, An Increase Of 71% YoY

For Q2 Wix Expects Total Revenue Of $431M-$435M Vs. $435.211M Consensus

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has become a $2 trillion company, thanks to a single act of kindness from a former Sega executive. This act saved the company from bankruptcy and set it on the path to becoming one of the world&#8217;s most valuable companies.
What Happened: In the 1990s, Nvidia was on the brink of collapse. Its first chip was a failure, and the next one was also doomed. It was at this critical juncture that Jensen Huang, Nvidia&#8217;s CEO, sought a $5 million lifeline from Shoichiro Irimajiri, a top Sega executive. Despite having no obligation to do so, Irimajiri provided the much-needed funds, as <a href="https://www.wsj.com/business/nvidia-stock-jensen-huang-sega-irimajiri-chips-ai-906247db">reported</a> by The Wall Street Journal.
&#8220;To his credit,&#8221; Huang said, &#8220;and my amazement.&#8221;
It was this act of kindness that saved Nvidia, and it&#8217;s a lesson Huang has never forgotten. &#8220;You can't discount the kindness of people when you're starting your company,&#8221; he said.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38909046/top-trader-ditches-bitcoin-for-altcoins-dogecoin-killer-shiba-inus-potential-breakout-and-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Top Trader Ditches Bitcoin For Altcoins, &#8216;Dogecoin Killer&#8217; Shiba Inu&#8217;s Potential Breakout And More</a>
Irimajiri, a legendary engineer and charismatic executive, played a crucial role in Nvidia&#8217;s history. He was the driving force behind Sega&#8217;s decision to tap Nvidia to build the graphics-processing unit for the Dreamcast console. Despite initial setbacks, Irimajiri continued to believe in Huang and his vision for the company.
Thanks to Irimajiri&#8217;s support, Nvidia was able to develop the breakthrough chip that saved the company. In 1999, Nvidia went public, and the rest, as they say, is history.
Why It Matters: Nvidia&#8217;s remarkable journey from the brink of bankruptcy to a $2 trillion valuation is a testament to the power of resilience and the impact of a single act of kindness. This story also underscores the critical role that early investors and supporters play in the success of a company.
Nvidia&#8217;s rise to the top has been accompanied by a surge in the stock market. The company&#8217;s <a href="https://www.benzinga.com/news/24/05/38908128/from-tokyo-to-new-york-stock-markets-are-hitting-unprecedented-highs-report">record-breaking performance</a> has been part of a global trend, with 14 of the world&#8217;s 20 largest stock markets hitting all-time highs.
However, Nvidia&#8217;s position as an industry leader is <a href="https://www.benzinga.com/news/24/05/38892874/nvidia-faces-new-competition-as-qualcomm-and-ampere-launch-ai-focused-server">facing new challenges</a>. Qualcomm and Ampere Computing have launched an AI-focused server, and Microsoft is introducing AMD AI chips to <a href="https://www.benzinga.com/markets/equities/24/05/38890649/microsoft-unveils-amd-powered-ai-chips-to-rival-nvidia-report">compete with Nvidia&#8217;s components</a>. These developments could impact Nvidia&#8217;s future performance and its ability to maintain its position as a market leader.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/05/38890222/biden-hands-out-big-l-to-trump-as-dow-hits-40k-for-first-time-and-ex-presidents-stock-market-cra?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden Hands Out &#8216;Big L&#8217; To Trump As Dow Hits 40K For First Time And Ex-President&#8217;s Stock Market Crash Prediction Falls Flat</a>
Image Via Shutterstock 
<hr class="wp-block-separator has-alpha-channel-opacity" />
Engineered by Benzinga Neuro, Edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Learn more.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />

Equities

Global

Startups

Markets

NVDA

Nvidia's $2 Trillion Success Story: How An Act Of Kindness From A Top Sega Executive Saved The Jensen Huang-Led Company In Its Infancy

Given&nbsp;Q1&nbsp;outperformance along with continued robust cohort behavior and strong business trends, we are increasing full year bookings&nbsp;outlook&nbsp;to&nbsp;$1,796&nbsp;-&nbsp;$1,826&nbsp;million, or&nbsp;12-14%&nbsp;y/y growth.&nbsp;The midpoint of this updated&nbsp;outlook&nbsp;is&nbsp;~$13 million&nbsp;higher than the midpoint of our previous&nbsp;outlook&nbsp;of&nbsp;$1,784&nbsp;-&nbsp;$1,813&nbsp;million.
This increase reflects 2H24 y/y bookings growth acceleration in both Self Creators and Partners. Self Creators growth acceleration is expected to be propelled by AI products driving higher conversion and product attach. Partners growth acceleration is expected to be primarily driven by Studio ramping and contributing more meaningfully through the year than initially planned. This increase in&nbsp;outlook&nbsp;also reflects better than expected dynamics around the price increase we implemented this quarter as renewals prove to be stickier and retention of existing users higher than expected.&nbsp;We now expect total bookings in the second half of 2024 to accelerate to&nbsp;16%&nbsp;at the high end of our&nbsp;guidance&nbsp;range, up from&nbsp;15%&nbsp;as previously anticipated.&nbsp;We continue to expect Creative Subscriptions bookings to accelerate to double digit y/y growth in 2H24.

Wix.Com 2024 Outlook, Raised: Now Expects Total Bookings Of $1.796B-$1.826B (Prior $1.78B-$1.81B) And Revenue Of $1.738B-$1.761B (Prior $1.725B-$1.757B) Vs. $1.75B Consensus

Sohu.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHU#NASDAQ">SOHU</a>) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.49) by 32.65 percent. This is a 75.68 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $139.390 million in sales this quarter. This is a 13.85 percent decrease over sales of $161.793 million the same period last year.

Earnings Misses

Sohu.com Q1 2024 Adj EPS $(0.65) Misses $(0.49) Estimate, Sales $139.390M Down From $161.793M YoY

Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.03 by 25.24 percent. This is a 41.76 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $419.776 million which beat the analyst consensus estimate of $417.837 million by 0.46 percent. This is a 12.22 percent increase over sales of $374.076 million the same period last year.

Earnings Beats

Wix.com Q1 2024 Adj EPS $1.29 Beats $1.03 Estimate, Sales $419.776M Beat $417.837M Estimate

Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE&#39;s impact on COPD exacerbations in patients with a broad range of eosinophil levels
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or smoking status.1&nbsp;The primary results showed that treatment with AstraZeneca and Amgen&#39;s TEZSPIRE&reg;&nbsp;(tezepelumab) led to a&nbsp;17%&nbsp;numerical reduction in the annual rate of moderate or severe COPD exacerbations compared to placebo at week 52, which was not statistically significant (90%&nbsp;CI (Confidence Interval): -6, 36], p [1-sided]=0.1042).1&nbsp;The results are being presented at the American Thoracic Society (ATS) International Conference.
Importantly, in patients with BEC &ge;150 cells/&micro;L, tezepelumab led to a nominally significant reduction of&nbsp;37%&nbsp;in the rate of moderate or severe exacerbations compared to placebo.1&nbsp;Studies suggest that approximately&nbsp;65%&nbsp;of bio-eligible patients with COPD have a BEC greater than or equal to 150 cells/&mu;L.2&nbsp;In patients with BEC &ge;300 cells/&micro;L tezepelumab led to a numerical reduction of&nbsp;46%&nbsp;in the rate of moderate or severe exacerbations.1&nbsp;(Table 1.)

AMGN

Reported Sunday, AstraZeneca And Amgen's TEZSPIRE Shows Potential For Future Chronic Obstructive Pulmonary Diseasetreatment In New Data Presented At ATS 2024

Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) reported quarterly earnings of RMB7.58 per share which beat the analyst consensus estimate of RMB7.16 by 5.87 percent. This is a 28.04 percent increase over earnings of RMB5.92 per share from the same period last year. The company reported quarterly sales of RMB4.153 billion which missed the analyst consensus estimate of RMB4.213 billion by 1.42 percent. This is a 15.39 percent increase over sales of RMB3.599 billion the same period last year.

QFIN

Reported Sunday, Qifu Technology Q1 2024 Adj EPS RMB7.58 Beats RMB7.16 Estimate, Sales RMB4.153B Miss RMB4.213B Estimate

Virios Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) (the &quot;Company&quot; or &quot;Virios Therapeutics&quot;), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (&quot;FM&quot;) and Long-COVID (&quot;LC&quot;), today announced the pricing of its previously announced public offering of 8,500,000 shares of its common stock at a public offering price of&nbsp;$0.20&nbsp;per share. Gross proceeds from the offering are expected to be approximately&nbsp;$1.7 million&nbsp;before deducting placement agent fees and estimated offering expenses. The offering is expected to close on May 22, 2024, subject to customary closing conditions. Virios Therapeutics intends to use the net proceeds of the proposed offering to commence preparatory activities for its planned IMC-2 Long-COVID Phase 2b study and for general corporate purposes.

VIRI

Reported Earlier, Virios Therapeutics Prices $1.7M Public Offering Of 8.5M Common Stock To Commence Preparations For Planned IMC-2 Long-COVID Phase 2b Study At $0.20/Share

<ul>
<li>Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization</li>
<li>China NMPA approval based on comprehensive clinical data demonstrating robust activity of SUL-DUR&nbsp;against carbapenem-resistant bacterial strains</li>
<li>In China, it is estimated there are approximately 300,000 cases of Acinetobacter infections and approximately&nbsp;74%&nbsp;of them are carbapenem-resistant</li>
</ul>

INVA

ZLAB

Zai Lab And Innoviva Specialty Therapeutics Receives NMPA Approval For XACDURO (Sulbactam-Durlobactam) For Hospital-Acquired And Ventilator-Associated Pneumonia Caused By Acinetobacter Baumannii-Calcoaceticus Complex In China

Macro Economic Events

Econ #s

Economics

BBJP

WisdomTree Trust Japan Total Dividend Fund

Japan Tertiary Industry Activity Index (MoM) -2.4% Vs. 0.1% Est.; 1.5% Prior

<a href="https://www.cnbc.com/2024/05/20/taiwan-new-president-lai-ching-te-takes-office-amid-tensions-with-china.html">https://www.cnbc.com/2024/05/20/taiwan-new-president-lai-ching-te-takes-office-amid-tensions-with-china.html</a>
<ul>
<li>Taiwan&#39;s new president, Lai Ching-te, was sworn in on Monday, amid rising tensions with China which is deeply suspicious of the current leadership.</li>
<li>Lai&#39;s takes over from his predecessor Tsai Ing-wen after securing a victory in January&#39;s election&nbsp;that ushered in an unprecedented third presidential term for the Democratic Progressive Party.</li>
</ul>
Taiwan&#39;s new president, Lai Ching-te, was sworn in on Monday, amid rising tensions with China which is deeply suspicious of the current leadership and has previously referred to the incoming leader as a &quot;stubborn worker&quot; for the island&#39;s independence.
Lai takes over from his predecessor Tsai Ing-wen after securing a <a href="https://www.cnbc.com/2024/01/13/taiwan-2024-election-dpps-lai-ching-te-wins.html">victory in January&#39;s election&nbsp;</a>that ushered in an unprecedented third presidential term for the Democratic Progressive Party.
&nbsp;
Together with Lai, Hsiao Bi-khim, 52, a former de facto Taiwan ambassador to the United States, was also sworn in as vice president.
Lai is widely expected to reaffirm the status quo in cross-strait relations with China.
He earlier pledged commitment to Tsai&#39;s foreign and defense policies of strengthening the island&#39;s ties with the United States and its allies as well as boosting defense capabilities.

&nbsp;
Beijing considers democratically governed Taiwan as its own territory and Chinese&nbsp;President&nbsp;Xi Jinping&nbsp;regards reunification with the mainland &quot;<a href="http://www.gwytb.gov.cn/topone/202312/t20231231_12590901.htm">a historical inevitability</a>.&quot;
China has repeatedly denounced Lai as a &quot;<a href="http://www.gwytb.gov.cn/xwdt/xwfb/wyly/202401/t20240111_12592825.htm">stubborn worker for Taiwan independence</a>&quot; and a dangerous separatist. In recent weeks, Beijing has increased military incursions around the island ahead of the Lai&#39;s inauguration, <a href="https://www.straitstimes.com/asia/china-military-incursions-inch-closer-to-taiwan-sources-say">according to Reuters.</a>
&nbsp;
This has been a thorny issue in Beijing&#39;s complex relationship with the U.S., which <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/01/13/remarks-by-president-biden-before-marine-one-departure-41/">does not support Taiwan independence</a> but has called for <a href="https://www.whitehouse.gov/briefing-room/press-briefings/2024/01/11/background-press-call-by-a-senior-administration-official-on-taiwan-elections/#:~:text=We%20do%20not%20support%20Taiwan,both%20sides%20of%20the%20Strait.">cross-Strait differences to be resolved peacefully</a>, &quot;in a manner that is acceptable to the people on both sides of the Strait.&quot;
Xi told his U.S. counterpart&nbsp;<a href="https://www.cnbc.com/joe-biden/">Joe Biden</a>&nbsp;on the sidelines of the APEC leaders summit in November that Taiwan has always been the &quot;<a href="https://www.mfa.gov.cn/eng/zxxx_662805/202311/t20231116_11181442.html">most important and sensitive</a>&quot; issue in China-U.S. relations.
While Lai won the presidency in January, the DPP lost its majority in the legislature and only has a narrow mandate. &nbsp;
Kuomintang or KMT, Beijing&#39;s preferred political partner, has more seats than the DPP but not enough to have a majority on its own.&nbsp;

'Taiwan's New President Lai Ching-Te Takes Office Amid Tensions With China' - CNBC

Reported Earlier, People's Bank of China Loan Prime Rate Unchanged At 3.45%

Reported Earlier, China Loan Prime Rate 5Y For May Unchanged At 3.95%

Iranian state news agency IRINN and semi-official news agency Mehr News reported that there were &#8220;no survivors&#8221; at the crash site of the helicopter carrying President Ebrahim Raisi.
What Happened: Raisi, a former hardline judiciary chief, became Iran&#8217;s eighth president in 2021 after a historically uncompetitive presidential election. As a former prosecutor and judge, he oversaw a period of intensified repression of dissent, according to human rights monitors, <a href="https://edition.cnn.com/middleeast/live-news/raisi-iran-president-helicopter-crash/index.html">according</a> to CNN.
Raisi was seen as a close ally of Iran&#8217;s Supreme Leader, Ayatollah Ali Khamenei, and was widely believed to be his potential successor.
The <a href="https://www.benzinga.com/news/24/05/38909714/iranian-presidents-helicopter-crashes-in-mountainous-terrain-official-says-leaders-life-at-risk">helicopter crash</a> occurred while Raisi was returning from a visit to the border with Azerbaijan. The aircraft crashed in mountainous terrain amid heavy fog, with the lives of Raisi and his foreign minister reportedly &#8220;at risk.&#8221;
Earlier, Hamas expressed &#8220;great concern&#8221; following the crash of a helicopter carrying Iranian President Ebrahim Raisi and other officials on Sunday. The details of the crash remain unclear, and Hamas showed &#8220;solidarity&#8221; with the president and the Iranian people.
&#8220;In this painful incident, we express our full solidarity with the Islamic Republic of Iran, its leadership, government, and people, and we ask Allah Almighty to protect and ensure the safety of the Iranian President and his accompanying delegation, and to keep all harm away from the brotherly Iranian people,&#8221; the Hamas statement reads.
According to a statement from China&#8217;s Ministry of Foreign Affairs, China expressed deep concern over the &#8220;hard landing&#8221; of the helicopter carrying Iran&#8217;s President Ebrahim Raisi.
"Following closely reports that the helicopter carrying the Iranian President and the foreign minister has been forced to land unexpectedly," European Council President Charles Michel said on the social media platform X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Following closely reports that the helicopter carrying the Iranian President and the foreign minister has been forced to land unexpectedly and their condition not yet clear. Together with EU member states and partners, we are monitoring the situation closely.
&mdash; Charles Michel (@CharlesMichel) <a href="https://twitter.com/CharlesMichel/status/1792215176889983158?ref_src=twsrc%5Etfw">May 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/05/38907930/anthony-scaramucci-labels-donald-trumps-hush-money-trial-as-obligatory-loyalty-test-for-republicans?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Anthony Scaramucci Labels Donald Trump&#8217;s Hush Money Trial As &#8216;Obligatory Loyalty Test&#8217; For Republicans, Says &#8216;It&#8217;ll Never Be Enough For Donald Trump&#8217;</a>
Why It Matters: The helicopter crash comes at a time of heightened tension in the region. Just last month, Iran&#8217;s President was in Pakistan to <a href="https://www.benzinga.com/news/24/04/38352545/irans-president-ebrahim-raisi-lands-in-pakistan-amid-tensions-seeks-to-repair-bilateral-relations-an">mend bilateral relations</a> amid military actions that had strained the two countries&#8217; ties. 
The visit was seen as a significant step towards normalizing relations, although the ultimate authority on state matters, including nuclear policy, lies with Iran's Supreme Leader Khamenei.
Earlier in April, Iran&#8217;s state-aligned media reported that the <a href="https://www.benzinga.com/news/24/04/38328453/iran-says-nuclear-facilities-safe-after-israeli-strike-us-confirms-escalation">nuclear facilities in Isfahan province</a> were safe following an Israeli strike. The attack, which was confirmed by a U.S. official, was not believed to have targeted nuclear installations.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/05/38910114/elon-musk-counts-amazing-president-joe-biden-among-tesla-naysayers-who-wish-to-see-the-ev-maker-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Counts &#8216;Amazing&#8217; President Joe Biden Among Tesla &#8216;Naysayers&#8217; Who Wish To See The EV Maker Go Bankrupt</a>
Image Via Shutterstock 
This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for DKSH Holding Stock (OTC:DKSHF)

Friday, February 22, 2019